Avanos Medical (AVNS) Shares Outstanding (2014 - 2026)

Avanos Medical's Shares Outstanding history runs 13 years deep, the most recent figure standing at $46.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 0.94% year-over-year to $46.7 million; the TTM figure through Mar 2026 stood at $46.7 million (up 0.94% YoY), while the FY2025 annual figure was $46.5 million, up 1.07% from the prior year.
• Shares Outstanding came in at $46.7 million for Q1 2026 at Avanos Medical, roughly flat from $46.5 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $47.3 million in Q1 2022 to a low of $45.9 million in Q2 2024.
• A 5-year average of $46.4 million and a median of $46.4 million in 2023 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding decreased 3.48% in 2022 and grew 1.07% in 2025, its largest moves.
• Avanos Medical's Shares Outstanding stood at $46.5 million in 2022, then declined by 0.76% to $46.2 million in 2023, then dropped by 0.46% to $46.0 million in 2024, then grew by 1.07% to $46.5 million in 2025, then advanced by 0.47% to $46.7 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $46.7 million, $46.5 million, and $46.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison